Skip to main content
Erschienen in: Immunologic Research 6/2018

21.12.2018 | Review

Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis

verfasst von: C. Barbati, M. Vomero, T. Colasanti, F. Ceccarelli, M. Marcosano, F. Miranda, L. Novelli, A. Pecani, Carlo Perricone, F. R. Spinelli, S. Truglia, F. Conti, G. Valesini, C. Alessandri

Erschienen in: Immunologic Research | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Microparticles (MPs) are small membrane vesicles released by many cell types under physiological and pathological conditions. In the last years, these particles were considered as inert cell debris, but recently many studies have demonstrated they could have a role in intercellular communication. Increased levels of MPs have been reported in various pathological conditions including infections, malignancies, and autoimmune diseases, such as rheumatoid arthritis (RA). RA is an autoimmune systemic inflammatory disease characterized by chronic synovial inflammation, resulting in cartilage and bone damage with accelerated atherosclerosis increasing mortality. According to the literature data, also MPs could have a role in endothelial dysfunction, contributing to atherosclerosis in RA patients. Moreover many researchers have shown that a dysregulated autophagy seems to be involved in endothelial dysfunction. Autophagy is a reparative process by which cytoplasmic components are sequestered in double-membrane vesicles and degraded on fusion with lysosomal compartments. It has been shown in many works that basal autophagy is essential to proper vascular function. Taking into account these considerations, we hypothesized that in RA patients MPs could contribute to atherosclerosis process by dysregulation of endothelial autophagy process.
Literatur
2.
Zurück zum Zitat Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21:157–71.CrossRefPubMed Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21:157–71.CrossRefPubMed
3.
Zurück zum Zitat Morel O, Toti F, Hugel B, Freyssinet J-M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol. 2004;11:156–64.CrossRefPubMed Morel O, Toti F, Hugel B, Freyssinet J-M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol. 2004;11:156–64.CrossRefPubMed
4.
Zurück zum Zitat Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem FEBS. 1982;122:429–36.CrossRef Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem FEBS. 1982;122:429–36.CrossRef
5.
Zurück zum Zitat Schroit AJ, Tanaka Y, Madsen J, Fidler IJ. The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetry. Biol Cell Auspices Eur Cell Biol Organ. 1984;51:227–38. Schroit AJ, Tanaka Y, Madsen J, Fidler IJ. The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetry. Biol Cell Auspices Eur Cell Biol Organ. 1984;51:227–38.
6.
Zurück zum Zitat Erdbrugger U, Le TH. Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol. 2016;27:12–26.CrossRefPubMed Erdbrugger U, Le TH. Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol. 2016;27:12–26.CrossRefPubMed
7.
Zurück zum Zitat Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345–53.CrossRefPubMed Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345–53.CrossRefPubMed
8.
Zurück zum Zitat Connor DE, Exner T, Ma DD, Joseph JE. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis. 2009;20:558–64.CrossRefPubMed Connor DE, Exner T, Ma DD, Joseph JE. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis. 2009;20:558–64.CrossRefPubMed
9.
Zurück zum Zitat Morel O, Toti F, Freyssinet JM. Markers of thrombotic disease: procoagulant microparticles. Ann Pharm Fr. 2007;65:75–84.CrossRefPubMed Morel O, Toti F, Freyssinet JM. Markers of thrombotic disease: procoagulant microparticles. Ann Pharm Fr. 2007;65:75–84.CrossRefPubMed
10.
Zurück zum Zitat Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004;286:1910–5.CrossRef Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004;286:1910–5.CrossRef
11.
Zurück zum Zitat Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007;110:2432–9.CrossRefPubMed Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007;110:2432–9.CrossRefPubMed
12.
Zurück zum Zitat Teruel R, Corral J, Perez-Andreu V, Martinez-Martinez I, Vicente V, Martinez C. Potential role of miRNAs in developmental haemostasis. PLoS One. 2011;6:e17648.CrossRefPubMedPubMedCentral Teruel R, Corral J, Perez-Andreu V, Martinez-Martinez I, Vicente V, Martinez C. Potential role of miRNAs in developmental haemostasis. PLoS One. 2011;6:e17648.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Turpin D, Truchetet ME, Faustin B, Augusto JF, Contin-Bordes C, Brisson A, et al. Role of extracellular vesicles in autoimmune diseases. Autoimmun Rev. 2016;15:174–83 Review.CrossRefPubMed Turpin D, Truchetet ME, Faustin B, Augusto JF, Contin-Bordes C, Brisson A, et al. Role of extracellular vesicles in autoimmune diseases. Autoimmun Rev. 2016;15:174–83 Review.CrossRefPubMed
14.
Zurück zum Zitat Habets KL, Trouw LA, Levarht EW, Korporaal SJ, Habets PA, de Groot P, et al. Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. Arthritis Res Ther. 2015;17:209.CrossRefPubMedPubMedCentral Habets KL, Trouw LA, Levarht EW, Korporaal SJ, Habets PA, de Groot P, et al. Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. Arthritis Res Ther. 2015;17:209.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Nielsen CT, Rasmussen NS, Heegaard NH, Jacobsen S. “Kill” the messenger: targeting of cell-derived microparticles in lupus nephritis. Autoimmun Rev. 2016;15:719–25 Review.CrossRefPubMed Nielsen CT, Rasmussen NS, Heegaard NH, Jacobsen S. “Kill” the messenger: targeting of cell-derived microparticles in lupus nephritis. Autoimmun Rev. 2016;15:719–25 Review.CrossRefPubMed
18.
Zurück zum Zitat Miwa Y, Takahashi R, Ikari Y, Maeoka A, Nishimi S, Oguro N, et al. Clinical characteristics of rheumatoid arthritis patients achieving functional remission with six months of biological DMARDs treatment. Intern Med. 2017;56:903–6.CrossRefPubMedPubMedCentral Miwa Y, Takahashi R, Ikari Y, Maeoka A, Nishimi S, Oguro N, et al. Clinical characteristics of rheumatoid arthritis patients achieving functional remission with six months of biological DMARDs treatment. Intern Med. 2017;56:903–6.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum. 2002;46:1498–503.CrossRefPubMed Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum. 2002;46:1498–503.CrossRefPubMed
20.
Zurück zum Zitat Hsu J, Gu Y, Tan SL, Narula S, DeMartino JA, Liao C. Bruton’s tyrosine kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints. Immunol Lett. 2013;150:97–104.CrossRefPubMed Hsu J, Gu Y, Tan SL, Narula S, DeMartino JA, Liao C. Bruton’s tyrosine kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints. Immunol Lett. 2013;150:97–104.CrossRefPubMed
21.
Zurück zum Zitat Berckmans RJ, Nieuwland R, Tak PP, Böing AN, Romijn FP, Kraan MC, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 2002;46:2857–66.CrossRefPubMed Berckmans RJ, Nieuwland R, Tak PP, Böing AN, Romijn FP, Kraan MC, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 2002;46:2857–66.CrossRefPubMed
22.
Zurück zum Zitat Berckmans RJ, Nieuwland R, Kraan MC, Schaap MC, Pots D, Smeets TJ, et al. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther. 2005;7:536–44.CrossRef Berckmans RJ, Nieuwland R, Kraan MC, Schaap MC, Pots D, Smeets TJ, et al. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther. 2005;7:536–44.CrossRef
23.
Zurück zum Zitat Low JM, Moore TL. A role for the complement system in rheumatoid arthritis. Curr Pharm Des. 2005;11:655–70.CrossRefPubMed Low JM, Moore TL. A role for the complement system in rheumatoid arthritis. Curr Pharm Des. 2005;11:655–70.CrossRefPubMed
24.
Zurück zum Zitat Grant EP, Picarella D, Burwell T, Delaney T, Croci A, Avitahl N, et al. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med. 2002;196:1461–71.CrossRefPubMedPubMedCentral Grant EP, Picarella D, Burwell T, Delaney T, Croci A, Avitahl N, et al. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med. 2002;196:1461–71.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Dye JR, Ullal AJ, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Scand J Immunol. 2013;78:140–8 Review.CrossRefPubMed Dye JR, Ullal AJ, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Scand J Immunol. 2013;78:140–8 Review.CrossRefPubMed
26.
Zurück zum Zitat Biró E, Nieuwland R, Tak PP, Pronk LM, Schaap MC, Sturk A, et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis. 2007;66:1085–92.CrossRefPubMedPubMedCentral Biró E, Nieuwland R, Tak PP, Pronk LM, Schaap MC, Sturk A, et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis. 2007;66:1085–92.CrossRefPubMedPubMedCentral
27.
28.
Zurück zum Zitat Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol. 2010;6:21–9.CrossRefPubMed Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol. 2010;6:21–9.CrossRefPubMed
29.
Zurück zum Zitat Reich N, Beyer C, Gelse K. Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts. J Cell Mol Med. 2011;15:756–62.CrossRefPubMed Reich N, Beyer C, Gelse K. Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts. J Cell Mol Med. 2011;15:756–62.CrossRefPubMed
30.
Zurück zum Zitat Amaya-Amaya J, Sarmiento-Monroy J, Mantilla R, Pineda-Tamayo R, Rojas-Villarraga A, Anaya J. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res. 2013;56:267–86.CrossRefPubMed Amaya-Amaya J, Sarmiento-Monroy J, Mantilla R, Pineda-Tamayo R, Rojas-Villarraga A, Anaya J. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res. 2013;56:267–86.CrossRefPubMed
31.
Zurück zum Zitat Aviña-Zubieta JA, Choi HK, Sadatsafavi M. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7.CrossRefPubMed Aviña-Zubieta JA, Choi HK, Sadatsafavi M. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7.CrossRefPubMed
32.
Zurück zum Zitat Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524–9.CrossRefPubMed Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524–9.CrossRefPubMed
33.
Zurück zum Zitat Szekanecz Z, Kerekes G, Dér H. Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci. 2007;1108:349–58.CrossRefPubMed Szekanecz Z, Kerekes G, Dér H. Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci. 2007;1108:349–58.CrossRefPubMed
34.
Zurück zum Zitat Södergren A, Karp K, Boman K. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther. 2010;12:R158.CrossRefPubMedPubMedCentral Södergren A, Karp K, Boman K. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther. 2010;12:R158.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Schmitz G, Grandl M. Lipid homeostasis in macrophages - implications for atherosclerosis. Rev Physiol Biochem Pharmacol. 2008;160:93–125.CrossRefPubMed Schmitz G, Grandl M. Lipid homeostasis in macrophages - implications for atherosclerosis. Rev Physiol Biochem Pharmacol. 2008;160:93–125.CrossRefPubMed
36.
37.
Zurück zum Zitat Mudau M, Genis A, Lochner A, Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23:222–31 Review.CrossRefPubMedPubMedCentral Mudau M, Genis A, Lochner A, Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23:222–31 Review.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Bijl M. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune disease. Neth J Med. 2003;60:273–7. Bijl M. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune disease. Neth J Med. 2003;60:273–7.
39.
Zurück zum Zitat Rabelink TJ, De Boer CH, van Zonneveld AJ. Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol. 2010;6:404–14.CrossRefPubMed Rabelink TJ, De Boer CH, van Zonneveld AJ. Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol. 2010;6:404–14.CrossRefPubMed
40.
42.
Zurück zum Zitat Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63:1–11.CrossRefPubMed Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63:1–11.CrossRefPubMed
43.
Zurück zum Zitat Szotowski B, Antoniak S, Goldin-Lang P. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc Res. 2007;73:806–12.CrossRefPubMed Szotowski B, Antoniak S, Goldin-Lang P. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc Res. 2007;73:806–12.CrossRefPubMed
44.
Zurück zum Zitat Lozito TP, Tuan RS. Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol. 2012;227:534–49.CrossRefPubMedPubMedCentral Lozito TP, Tuan RS. Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol. 2012;227:534–49.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Mallat Z, Benamer H, Hugel B. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101:841–3.CrossRefPubMed Mallat Z, Benamer H, Hugel B. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101:841–3.CrossRefPubMed
46.
Zurück zum Zitat Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AC, et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res. 2011;108:335–43.CrossRefPubMed Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AC, et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res. 2011;108:335–43.CrossRefPubMed
47.
Zurück zum Zitat Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem. 1999;274:23111–8.CrossRefPubMed Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem. 1999;274:23111–8.CrossRefPubMed
48.
Zurück zum Zitat Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol. 1994;112:519–24.CrossRefPubMedPubMedCentral Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol. 1994;112:519–24.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Tan KT, Lip GYH. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost. 2005;94:488–92.CrossRefPubMed Tan KT, Lip GYH. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost. 2005;94:488–92.CrossRefPubMed
51.
Zurück zum Zitat Duchez A-C, Boudreau LH, Naika GS, Bollinger J, Belleannée C, Cloutier N, et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci U S A. 2015;112:3564–73.CrossRef Duchez A-C, Boudreau LH, Naika GS, Bollinger J, Belleannée C, Cloutier N, et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci U S A. 2015;112:3564–73.CrossRef
52.
Zurück zum Zitat Rodriguez-Carrio J, López P, Alperi-Lopez M. Angiogenic T cells and derived microparticles disturbances in rheumatoid arthritis patients. Ann Rheum Dis. 2014;73:A33.CrossRef Rodriguez-Carrio J, López P, Alperi-Lopez M. Angiogenic T cells and derived microparticles disturbances in rheumatoid arthritis patients. Ann Rheum Dis. 2014;73:A33.CrossRef
53.
Zurück zum Zitat Carrio JR, López MA, Francisco PL, Ballina-García J, Suárez A. Good response to tumour necrosis factor alpha blockade results in an angiogenic T cell recovery in rheumatoid arthritis patients. Rheumatology. 2015;54:1129–31.CrossRef Carrio JR, López MA, Francisco PL, Ballina-García J, Suárez A. Good response to tumour necrosis factor alpha blockade results in an angiogenic T cell recovery in rheumatoid arthritis patients. Rheumatology. 2015;54:1129–31.CrossRef
54.
Zurück zum Zitat Deter RL, De Duve C. Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J Cell Biol. 1967;33:437–49.CrossRefPubMedPubMedCentral Deter RL, De Duve C. Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J Cell Biol. 1967;33:437–49.CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Schrijvers DM, De Meyer GR, Martinet W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol. 2011;31:2787–91.CrossRefPubMed Schrijvers DM, De Meyer GR, Martinet W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol. 2011;31:2787–91.CrossRefPubMed
57.
Zurück zum Zitat Martinet W, De Loof H, De Meyer GR. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis. 2014;233:601–7.CrossRefPubMed Martinet W, De Loof H, De Meyer GR. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis. 2014;233:601–7.CrossRefPubMed
58.
Zurück zum Zitat Martinet W, De Meyer GR. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res. 2009;104:304–17.CrossRefPubMed Martinet W, De Meyer GR. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res. 2009;104:304–17.CrossRefPubMed
59.
Zurück zum Zitat Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab. 2012;15:534–44.CrossRefPubMedPubMedCentral Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab. 2012;15:534–44.CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008;456:264–8.CrossRefPubMed Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008;456:264–8.CrossRefPubMed
61.
Zurück zum Zitat Torisu T, Torisu K, Lee IH. Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor. Nat Med. 2013;19:1281–7.CrossRefPubMedPubMedCentral Torisu T, Torisu K, Lee IH. Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor. Nat Med. 2013;19:1281–7.CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012;15:545–53.CrossRefPubMedPubMedCentral Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012;15:545–53.CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Le Guezennec X, Brichkina A, Huang YF, Kostromina E, Han W, Bulavin DV. Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab. 2012;16:68–80.CrossRefPubMed Le Guezennec X, Brichkina A, Huang YF, Kostromina E, Han W, Bulavin DV. Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab. 2012;16:68–80.CrossRefPubMed
65.
Zurück zum Zitat Xiong Y, Yepuri G, Forbiteh M, Y Y, JP Montani ZY, et al. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Autophagy. 2014;10:2223–38.CrossRefPubMed Xiong Y, Yepuri G, Forbiteh M, Y Y, JP Montani ZY, et al. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Autophagy. 2014;10:2223–38.CrossRefPubMed
66.
Zurück zum Zitat Peng N, Meng N, Wang S, Zhao F, Zhao J, Su L, et al. An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E−/− mice. Sci Rep. 2014;4:5519.CrossRefPubMedPubMedCentral Peng N, Meng N, Wang S, Zhao F, Zhao J, Su L, et al. An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E/ mice. Sci Rep. 2014;4:5519.CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat Zufeng D, Shijie L, Xianwei W, Magomed K, Yao D, Jawahar L. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep. 2013;3:1077.CrossRef Zufeng D, Shijie L, Xianwei W, Magomed K, Yao D, Jawahar L. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep. 2013;3:1077.CrossRef
68.
Zurück zum Zitat Wang Q, Zeng P, Liu Y, Wen G, Fu X, Sun X. Inhibition of autophagy ameliorates atherogenic inflammation by augmenting apigenin-induced macrophage apoptosis. Immunopharmacology. 2015;27:24–31.CrossRef Wang Q, Zeng P, Liu Y, Wen G, Fu X, Sun X. Inhibition of autophagy ameliorates atherogenic inflammation by augmenting apigenin-induced macrophage apoptosis. Immunopharmacology. 2015;27:24–31.CrossRef
69.
Zurück zum Zitat Salabei JK, Hill BG. Implications of autophagy for vascular smooth muscle cell function and plasticity. Free Radic Biol Med. 2013;65:693–703.CrossRefPubMed Salabei JK, Hill BG. Implications of autophagy for vascular smooth muscle cell function and plasticity. Free Radic Biol Med. 2013;65:693–703.CrossRefPubMed
Metadaten
Titel
Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis
verfasst von
C. Barbati
M. Vomero
T. Colasanti
F. Ceccarelli
M. Marcosano
F. Miranda
L. Novelli
A. Pecani
Carlo Perricone
F. R. Spinelli
S. Truglia
F. Conti
G. Valesini
C. Alessandri
Publikationsdatum
21.12.2018
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 6/2018
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-018-9053-0

Weitere Artikel der Ausgabe 6/2018

Immunologic Research 6/2018 Zur Ausgabe

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.